Suchergebnisse - "Church, Kevin J"

PubPharm (18)

11

Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma

enthalten in: Cytokine | 2019

von Vanderwerff, B. | Church, K. | Kawas, L. | +1

12

Hepatocyte Growth Factor and Macrophage-stimulating Protein "Hinge" Analogs to Treat Pancreatic Cancer

enthalten in: Current cancer drug targets | 2019

von Wright, J. | Church, K. | Harding, J.

13

Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer

enthalten in: Current cancer drug targets | 2019

von Wright, J. | Church, K. | Harding, J.

14

Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine

enthalten in: Anti-cancer drugs | 2018

von Church, K. | Vanderwerff, B. | Riggers, R. | +5

15

Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells

enthalten in: Anti-cancer drugs | 2016

von Church, K. | Vanderwerff, B. | Riggers, R. | +4

16

Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells

enthalten in: Anti-cancer drugs | 2016

von Church, K. | Vanderwerff, B. | Riggers, R. | +4

17

Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells

enthalten in: Anti-cancer drugs | 2016

von Church, K. | Vanderwerff, B. | Riggers, R. | +4

18

Study to determine the clinical significance of HEmolysis During Orbital AtheRectomy (CLEAR study)

enthalten in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists | 2011

von Staniloae, C. | Korabathina, R. | Lane, T. | +4

CommentIn: J Endovasc Ther. 2011 Feb;18(1):64-5. - PMID 21314351